Gómez González Marta Antonia, Cordero Tous Nicolás, Sánchez Corral Carlos, Lechuga Carrasco Beatriz, Sánchez García Manuel Alejandro, Gálvez Mateos Rafael, Olivares Granados Gonzalo
Functional Neurosurgery Unit, Department of Neurosurgery, Hospital Universitario Virgen de las Nieves, Juan Pablo II Avenue, S/N, 4th Floor, 18013 Granada, Spain.
Pain Unit, Department of Anesthesiology, Reanimation and Pain Management, Hospital Universitario Virgen de las Nieves, Juan Pablo II Avenue, S/N, 2nd Floor, 18013 Granada, Spain.
J Clin Med. 2025 Sep 21;14(18):6646. doi: 10.3390/jcm14186646.
Spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain. Although rechargeable and non-rechargeable pulse generators (PGs) are widely used, their real-world battery life and the influence of lead type on energy efficiency remain underexplored. To evaluate PG battery longevity and compare the performance of surgical versus percutaneous leads in terms of energy efficiency. We conducted a retrospective study of 283 PGs implanted at Hospital Virgen de las Nieves (Granada, Spain) from 1996 to 2023. Data on patient demographics, pain etiology, lead type and placement, stimulation modality, and PG status were extracted. A competing risks analysis was used to assess PG shutdown and early explantation over time. Of the PGs analyzed, 43.5% were non-rechargeable and 56.5% rechargeable. Rechargeable PGs showed significantly longer battery life (mean: 82.7 vs. 38.9 months, < 0.05), with a lower probability of shutdown at 50, 100, and 150 months. No significant differences in battery longevity were observed regarding lead location, stimulation type, or pain etiology. A trend toward longer battery life was observed with percutaneous leads, although not statistically significant. Rechargeable PGs demonstrated superior longevity compared to non-rechargeable models and should be considered the preferred option in most cases. While both surgical and percutaneous leads are effective, percutaneous systems may offer improved battery efficiency. Further prospective studies are warranted to confirm these findings and assess cost-effectiveness.
脊髓刺激(SCS)是一种治疗慢性神经性疼痛的成熟疗法。尽管可充电和不可充电脉冲发生器(PGs)被广泛使用,但其实际电池寿命以及导线类型对能量效率的影响仍未得到充分研究。为了评估PG电池的使用寿命,并比较手术导线与经皮导线在能量效率方面的性能。我们对1996年至2023年在西班牙格拉纳达的比维斯圣母医院植入的283个PGs进行了一项回顾性研究。提取了患者人口统计学、疼痛病因、导线类型和放置位置、刺激方式以及PG状态的数据。采用竞争风险分析来评估PG随时间的关机和早期取出情况。在分析的PGs中,43.5%是不可充电的,56.5%是可充电的。可充电PGs的电池寿命明显更长(平均:82.7个月对38.9个月,<0.05),在50、100和150个月时关机的概率更低。在电池使用寿命方面,未观察到导线位置、刺激类型或疼痛病因的显著差异。经皮导线观察到有电池寿命延长的趋势,尽管无统计学意义。与不可充电型号相比,可充电PGs的使用寿命更长,在大多数情况下应被视为首选选项。虽然手术导线和经皮导线都有效,但经皮系统可能具有更高的电池效率。需要进一步的前瞻性研究来证实这些发现并评估成本效益。